Clinical Trials Scorecard for Clinical Trial Investigations 2023-2024
01 mai 2024 09h42 HE
|
Research and Markets
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023" report has been added to ResearchAndMarkets.com's offering.The clinical trials...
Phenylketonuria (PKU) Global Clinical Trials Review 2024: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
01 mai 2024 09h40 HE
|
Research and Markets
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Phenylketonuria (Pku) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
01 mai 2024 09h00 HE
|
H1
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- H1, the digital health innovator on a mission to connect the world to the right doctors, today announced the appointment of Karen Walker to its Board of...
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives
01 mai 2024 08h05 HE
|
Tevogen Bio Inc
For full year 2023, the operating expenses for Tevogen Bio Inc were $8.8 million.
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
30 avr. 2024 08h30 HE
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Global Clinical Trials Review 2024: G7 & E7 Regional Insights, Phase, Trial Status, End-points Status and Sponsor Type
29 avr. 2024 07h47 HE
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Global Clinical Trials Review, 2024" clinical trials has been added to ...
Global CD70 Targeting Therapies Market & Clinical Trials Report 2024 - Insight by Company, Country, Indication & Phase
29 avr. 2024 07h32 HE
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024 - Groundbreaking Advances in PLK Targeted Therapies Promise to Revolutionize Treatment for Cancer and Other Diseases
29 avr. 2024 06h53 HE
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's...
Borderline Personality Disorder (BPD) Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
26 avr. 2024 06h07 HE
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The...
Obsessive-Compulsive Disorder (OCD) Global Clinical Trials Review 2024: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
25 avr. 2024 10h19 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The...